From the Department of Pathology, Memorial Hermann Southwest Hospital, Houston, Texas (Dr Brown); the Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston (Mr Della Speranza); the Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland (Ms Alvarez); the Department of Pathology, Greenwich Hospital, Greenwich, Connecticut (Dr Eisen); the Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California (Dr Frishberg); the Department of Pathology, University of Utah Medical School, Salt Lake City (Dr Rosai); the Histologic Technology Program, Florida State College at Jacksonville, Orange Park (Mr Santiago); the Department of Laboratory Medicine and Pathology, Royal Columbian Hospital, New Westminster, British Columbia, Canada (Ms Tunnicliffe); Governance (Ms Colasacco) and Surveys (Ms Thomas), College of American Pathologists, Northfield, Illinois; and the Quality and Guidelines Department, American Society of Clinical Oncology, Alexandria, Virginia (Ms Lacchetti).
Arch Pathol Lab Med. 2015 Dec;139(12):1515-24. doi: 10.5858/arpa.2014-0340-SA. Epub 2015 Apr 21.
The labeling of paraffin blocks and microscopic glass slides in the practice of surgical pathology varies from institution to institution and introduces potential risk of preanalytic error. Currently there are no evidence-based guidelines regarding the uniform labeling of these materials.
To develop recommendations that will address the need for adequate patient identification and provide a consistent method of identifying slides originating from a particular block.
Twelve guideline statements were established to assist pathology laboratories in developing standardized block and slide labeling practices. These guidelines call for the use of 2 patient identifiers, 1 of which includes the accession number and case type, on all paraffin blocks and slides. Recommendations were also developed to address the order and format in which identifying elements should appear.
Uniform labeling of paraffin blocks and slides derived from patient specimens will provide an important enhancement to patient safety by assuring that all preparations derived from a patient's tissue can be uniquely and unambiguously linked to that patient. Adoption of standardized practices additionally will improve patient care by facilitating interpretation of histologic sections when they are referred in consultation to a second institution.
在外科病理学实践中,石蜡块和显微镜玻璃载玻片的标签在不同机构之间存在差异,这引入了潜在的分析前误差风险。目前,关于这些材料的统一标签尚无循证指南。
制定建议,以满足充分识别患者的需求,并提供一种识别来自特定蜡块的载玻片的一致方法。
确定了 12 条指南声明,以协助病理实验室制定标准化的蜡块和载玻片标签实践。这些指南要求在所有石蜡块和载玻片上使用 2 个患者标识符,其中 1 个包括访问号和病例类型。还制定了建议,以解决识别元素应出现的顺序和格式问题。
对源自患者标本的石蜡块和载玻片进行统一标签将通过确保从患者组织获得的所有制剂都可以唯一且明确地与该患者相关联,从而为患者安全提供重要增强。采用标准化实践还将通过促进将组织学切片提交给第二家机构进行咨询时的解释,从而改善患者护理。